Trials / Completed
CompletedNCT06164236
Study of Predictors of Failure of Sulprostone Treatment in Postpartum Hemorrhage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators wish to identify potential factors predicting failure of second-line drug treatment (sulproston (Nalador®)): risk factors and factors linked to a failure to take initial care for PPH. A better understanding of the aggravating factors of HPP and more particularly the factors inherent to the initial care would make it possible to think of ways to improve practices.
Conditions
Timeline
- Start date
- 2020-10-19
- Primary completion
- 2024-04-19
- Completion
- 2024-04-19
- First posted
- 2023-12-11
- Last updated
- 2024-12-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06164236. Inclusion in this directory is not an endorsement.